Henderson, NV–(business wire)–Ontrack Co., Ltd. (NASDAQ:OTRK) (“Ontrak” or the “Company”), a leading AI-powered, telemedicine-enabled healthcare company, announced today that 30% of Ontrak Wholehealth+ members evaluated showed clinically significant relief of anxiety symptoms after 6 months announced the first evaluation results showing that it maintained Fifty-five percent sustained a clinically significant reduction in depressive symptoms. Ontrak Health conducts formal PHQ-9 and GAD-7 assessments to gain valuable insight into members’ mental health care progress and provide the support needed to manage and improve symptoms , one of the only behavioral services companies of its kind. It also helps health professionals tailor treatment plans and interventions to meet each patient’s specific needs.
In June 2022, Ontrak Health will convert the widely accepted PHQ-9 (Depression Severity Scale) and GAD-7 (Anxiety Severity Scale) assessments into an innovative care coaching model and evidence base. We implemented it as a base measure for our Wholehealth+ program based on: Although primarily used by healthcare providers, Ontrak Health has incorporated them into its care coaching model to facilitate better oversight, collaboration and accountability with healthcare providers and customers.
Thousands of assessments have been completed showing the results of over 1,000 unique program enrollees. Ontrak Care Coaches regularly reassess with members to look for trends in scores and monitor changes in symptoms.
Tracking a patient’s PHQ-9 and GAD-7 scores over time is useful for:
Monitoring Treatment Effectiveness: By tracking changes in assessment scores over time, medical professionals can measure the effectiveness of therapeutic interventions and identify and address problems early.
Progress Assessment: Assessment score trends help patients see their progress over time. This is especially useful for patients who may have a history of chronic symptoms or are experiencing new mental health issues.The data can be a valuable source of information in optimizing treatment. There is a nature.
“The inclusion of PHQ-9 and GAD-7 assessments in the Ontrak Wholehealth+ program is an important step in measuring improvements in members’ mental health. Regular assessment of members’ PHQ-9 and GAD-7 scores This provides valuable insight into members’ mental health care progress and helps providers tailor treatment plans to meet each member’s specific needs. By providing interpretation over time, members can better identify targeted mental health issues and become more engaged in treatment outcomes.”
Ontrak, Inc. is a leading AI and telemedicine-enabled healthcare company whose mission is to improve health and save lives for as many people as possible. Ontrak identifies, engages, activates, and delivers pathways of care to treatment for the most vulnerable members of the behavioral health population who would otherwise slip through the cracks of the healthcare system. We engage individuals with anxiety, depression, substance use disorders, and chronic illnesses through personalized care coaching and customized care pathways to address socioeconomic, medical, and health system barriers. Help them get the treatment and advocacy they need, albeit aggravating their severity.Comorbidities. The company’s integrated intervention platform uses AI, predictive analytics, and digital interfaces combined with dozens of care coach engagements to improve member health, increase utilization of healthcare systems, and deliver lasting results and healthcare outcomes. Provides cost savings to healthcare payers.
Learn more at www.ontrakhealth.com